68 related articles for article (PubMed ID: 2427802)
1. Azotemia during chronic converting enzyme inhibition with enalapril in sodium-depleted rats: role of renal circulatory changes.
Mento PF; Wilkes BM
J Cardiovasc Pharmacol; 1986; 8(4):670-5. PubMed ID: 2427802
[TBL] [Abstract][Full Text] [Related]
2. Renal haemodynamics and function in weanling rats treated with enalapril from birth.
Guron G
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):865-70. PubMed ID: 16173949
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
Laubie M; Schiavi P; Vincent M; Schmitt H
J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a vasodepressor effect of the angiotensin-converting enzyme inhibitor, MK421 (enalapril), independent of blockade of angiotensin II formation.
Wilkes BM
J Cardiovasc Pharmacol; 1984; 6(6):1036-42. PubMed ID: 6084759
[TBL] [Abstract][Full Text] [Related]
5. Systemic and regional hemodynamic effects of 1,25-dihydroxyvitamin D3 administration.
Roca-Cusachs A; DiPette DJ; Carson J; Graham GA; Holland OB
J Hypertens; 1992 Sep; 10(9):939-47. PubMed ID: 1328375
[TBL] [Abstract][Full Text] [Related]
6. Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat.
Jackson B; Cubela R; Debrevi L; Whitty M; Johnston CI
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S167-9. PubMed ID: 2455124
[TBL] [Abstract][Full Text] [Related]
7. Acute and chronic effects of a novel dihydrobenzofuran analogue and enalapril on blood pressure and plasma and tissue angiotensin converting enzyme activity in the sodium deficient normotensive rat.
Longman SD; Howlett DR
Arzneimittelforschung; 1988 May; 38(5):678-82. PubMed ID: 2843192
[TBL] [Abstract][Full Text] [Related]
8. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
9. An examination of chronic angiotensin-converting enzyme inhibition in the rat.
Blantz RC; Gushwa LC; Mundy CA; Peterson OW; Ziegler MG
Miner Electrolyte Metab; 1985; 11(4):249-55. PubMed ID: 2993837
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
[TBL] [Abstract][Full Text] [Related]
11. Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension.
O'Connor DT; Mosley CA; Cervenka J; Bernstein KN
J Hypertens Suppl; 1984 Dec; 2(2):S89-92. PubMed ID: 6100882
[TBL] [Abstract][Full Text] [Related]
12. Systemic and renal hemodynamic changes after two-month treatment with enalapril in patients with essential hypertension.
Valvo E; Gammaro L; Bedogna V; Tonon M; Giorgetti P; Pica B; Antonini P; Tessitore N; Oldrizzi L; Rugiu C
Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):656-9. PubMed ID: 2830196
[TBL] [Abstract][Full Text] [Related]
13. Renal function in one-kidney, one clip sodium-restricted rats: influence of enalapril and losartan.
Demeilliers B; Jover B; Mimran A
J Hypertens; 1995 Dec; 13(12 Pt 2):1764-6. PubMed ID: 8903648
[TBL] [Abstract][Full Text] [Related]
14. Effects of captopril on blood pressure, placental blood flow and uterine oxygen consumption in pregnant rabbits.
Binder ND; Faber JJ
J Pharmacol Exp Ther; 1992 Jan; 260(1):294-9. PubMed ID: 1731044
[TBL] [Abstract][Full Text] [Related]
15. [The renin-angiotensin system and renal adaptation to sodium restriction].
Mimran A; Jover B; Dupont M; Casellas D
Nephrologie; 1985; 6(3):127-31. PubMed ID: 3001555
[TBL] [Abstract][Full Text] [Related]
16. Systemic and renal effects of enalapril and its effects on cardiac mass.
Dunn FG; Oigman W; Ventura HO; Messerli FH; Kobrin I; Frohlich ED
J Hypertens Suppl; 1984 Dec; 2(2):S57-61. PubMed ID: 6100878
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of captopril and enalapril on the progression of chronic renal disease in partially nephrectomized rats.
Fettman MJ; Wilke WL; VanHouten DS; Hamar DW; Mikita DJ
Res Commun Chem Pathol Pharmacol; 1989 Aug; 65(2):131-46. PubMed ID: 2555851
[TBL] [Abstract][Full Text] [Related]
18. Renal function and urinary prostanoid excretions in salt-depleted women: comparative effects of enalapril and indomethacin treatments.
Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
Prostaglandins Leukot Essent Fatty Acids; 1999 Feb; 60(2):87-93. PubMed ID: 10328327
[TBL] [Abstract][Full Text] [Related]
19. Regional vasodilating effects of spirapril diacid and enalapril diacid in anesthetized dogs.
Noguchi K; Ojiri Y; Chibana T; Kinjo N; Moromizato H; Nakasone J; Sakanashi M
Arch Int Pharmacodyn Ther; 1991; 309():51-63. PubMed ID: 1888230
[TBL] [Abstract][Full Text] [Related]
20. Comparison of angiotensin converting enzyme and renin inhibition in rats following myocardial infarction.
Mento PF; Maita ME; Murphy WR; Holt WF; Wilkes BM
J Cardiovasc Pharmacol; 1993 May; 21(5):791-6. PubMed ID: 7685451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
